Literature DB >> 9525308

Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of nondividing cells.

K Miyake1, N Suzuki, H Matsuoka, T Tohyama, T Shimada.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-based vectors are thought to be useful for gene transfer into nondividing cells. We examined whether HIV vectors can really integrate into the chromosomes of nondividing cells. CD4+HeLa cells arrested at the G2 or G1/S phase were incubated with the HIV vector pseudotyped with the HIV envelope. The transduction efficiency of the HIV vector in these nondividing cells was comparable to that in proliferating cells. Sequencing of the polymerase chain reaction-amplified fragments containing the junction sites showed that the HIV vector was stably integrated into the chromosomal DNA. It was also demonstrated that terminally differentiated human macrophages and nonproliferating NT neurons could be transduced by the HIV vector after adenovirus-mediated expression of CD4. These results suggest that the HIV vector may be useful not only for gene therapy of AIDS but also for a variety of gene therapy protocols targeting nondividing cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525308     DOI: 10.1089/hum.1998.9.4-467

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

1.  Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells.

Authors:  H Mikkola; N B Woods; M Sjögren; H Helgadottir; I Hamaguchi; S E Jacobsen; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor.

Authors:  P Kurre; H P Kiem; J Morris; S Heyward; J L Battini; A D Miller
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes.

Authors:  Qiu Zhong; Dakshina Murthy Devanga Chinta; Sarala Pamujula; Haifan Wang; Xin Yao; Tarun K Mandal; Ronald B Luftig
Journal:  J Nanobiotechnology       Date:  2010-02-24       Impact factor: 10.435

Review 4.  Clinical gene therapy in hematology: past and future.

Authors:  J Richter; S Karlsson
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

5.  Transduction of interphase cells by avian sarcoma virus.

Authors:  Richard A Katz; James G Greger; Kristen Darby; Pamela Boimel; Glenn F Rall; Anna Marie Skalka
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Towards metabolic sink therapy for mut methylmalonic acidaemia: correction of methylmalonyl-CoA mutase deficiency in T lymphocytes from a mut methylmalonic acidaemia child by retroviral-mediated gene transfer.

Authors:  C C Chang; K J Hsiao; Y M Lee; C M Lin
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

7.  Human immunodeficiency virus vector-mediated intra-articular expression of angiostatin inhibits progression of collagen-induced arthritis in mice.

Authors:  Ko Kato; Koichi Miyake; Tsutomu Igarashi; Shinichi Yoshino; Takashi Shimada
Journal:  Rheumatol Int       Date:  2004-06-15       Impact factor: 2.631

8.  Calcium phosphate coprecipitation greatly enhances transduction of cardiac myocytes and vascular smooth muscle cells by lentivirus vectors.

Authors:  Tsuyoshi Sakoda; Nori Kasahara; Larry Kedes; Mitsumasa Ohyanagi
Journal:  Exp Clin Cardiol       Date:  2007

9.  The foamy virus genome remains unintegrated in the nuclei of G1/S phase-arrested cells, and integrase is critical for preintegration complex transport into the nucleus.

Authors:  Yung-Tsun Lo; Tao Tian; Peter E Nadeau; Jeonghae Park; Ayalew Mergia
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

10.  Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors.

Authors:  Francisco J Leyva; Joshua J Anzinger; J Philip McCoy; Howard S Kruth
Journal:  BMC Biotechnol       Date:  2011-01-31       Impact factor: 2.563

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.